CAT vs PMCB · P/E 48, rev $20.54B vs $8.6M cap
Caterpillar Inc (CAT) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the CAT and PMCB stock pages for the full models.
Not investment advice.